CytoSorb hemoadsorption in rhabdomyolysis-induced acute kidney injury: a case report from a tertiary hospital in Bangladesh
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253624Keywords:
Rhabdomyolysis, CytoSorb, Acute kidney injury, Hemoadsorption, Creatine phosphokinaseAbstract
Rhabdomyolysis is a serious clinical condition involving the breakdown of skeletal muscle, leading to the release of intracellular components into circulation. Among its complications, acute kidney injury (AKI) is the most critical, occurring in up to 50% of cases. This report presents the case of a 42-year-old male with schizophrenia and hypertension who developed rhabdomyolysis-induced AKI following a fall. He exhibited markedly elevated creatine phosphokinase (CPK) levels (360,000 u/l) and deteriorating renal function. In addition to supportive management, CytoSorb hemoadsorption was initiated. Over three sessions, CPK levels dropped to 174 u/l, and serum creatinine declined from 3.53 mg/dl to 2.16 mg/dl. This case demonstrates that CytoSorb therapy can be effective even in limited-resource settings where myoglobin assays are unavailable, offering a promising strategy for early intervention in rhabdomyolysis-induced AKI. Our experience suggests early initiation of hemoadsorption could serve as an effective adjunct in managing challenging cases where conventional therapies alone may be insufficient.
Metrics
References
Cervellin G, Comelli I, Benatti M, Sanchis‑Gomar F, Bassi A, Lippi G. Non‑traumatic rhabdomyolysis: background, laboratory features, and acute clinical management. Clin Biochem. 2017;50(12):656-62. DOI: https://doi.org/10.1016/j.clinbiochem.2017.02.016
Neves Pinto G, Campelo Fraga Y, de Francesco Daher E, Bezerra da Silva Júnior G. Acute kidney injury due to rhabdomyolysis: a review of pathophysiology, causes, and cases reported in the literature, 2011–2021. Rev Colomb Nefrol. 2023;10(3):e619. DOI: https://doi.org/10.22265/acnef.10.3.619
Zager RA, Foerder CA. Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity. J Clin Invest. 1992;89(3):989-96. DOI: https://doi.org/10.1172/JCI115682
Lu Y, Neyra JA. How I treat rhabdomyolysis-induced AKI? Clin J Am Soc Nephrol. 2024;19(3):385-7. DOI: https://doi.org/10.2215/CJN.0000000000000372
Cabral BMI, Edding SN, Portocarrero JP, Lerma EV. Rhabdomyolysis. Dis Mon. 2020;66(8):101015. DOI: https://doi.org/10.1016/j.disamonth.2020.101015
Safari S, Yousefifard M, Hashemi B, Baratloo A, Forouzanfar MM, Rahmati F, et al. The value of serum creatine kinase in predicting the risk of rhabdomyolysis-induced acute kidney injury: a systematic review and meta-analysis. Clin Exp Nephrol. 2016;20(2):153-61. DOI: https://doi.org/10.1007/s10157-015-1204-1
Chatzizisis YS, Misirli G, Hatzitolios AI, Giannoglou GD. The syndrome of rhabdomyolysis: complications and treatment. Eur J Intern Med. 2008;19(8):568-74. DOI: https://doi.org/10.1016/j.ejim.2007.06.037
Pieri M, Russo G, Francescon C, Fominskiy E, Nardelli P, Calabrò MG, et al. Dual concomitant CytoSorb hemoadsorption therapy in severe rhabdomyolysis: A novel approach to myoglobin clearance and organ preservation. Int J Artif Organs. 2025;48(6):429-33. DOI: https://doi.org/10.1177/03913988251339080
Albrecht F, Schunk S, Fuchs M, Volk T, Geisel J, Fliser D, et al. Rapid and effective elimination of myoglobin with CytoSorb in severe rhabdomyolysis. Blood Purif. 2024;53(2):88-95. DOI: https://doi.org/10.1159/000534479
Dilken O, Ince C, van der Hoven B, Thijsse S, Ormskerk P, de Geus HRH. Successful Reduction of Creatine Kinase and Myoglobin Levels in Severe Rhabdomyolysis Using Extracorporeal Blood Purification (CytoSorb®). Blood Purif. 2020;49(6):743-7. DOI: https://doi.org/10.1159/000505899
Heyne N, Guthoff M, Krieger J, Haap M, Häring HU. High cut-off renal replacement therapy for removal of myoglobin in severe rhabdomyolysis and acute kidney injury: a case series. Nephron Clin Pract. 2012;121(3-4):c159-64. DOI: https://doi.org/10.1159/000343564
de Fallois J, Scharm R, Lindner TH, Lindner TH, Scharf C, Petros S, et al. Kidney replacement and conservative therapies in rhabdomyolysis: a retrospective analysis. BMC Nephrol. 2024;25(1):96. DOI: https://doi.org/10.1186/s12882-024-03536-8
Graf H, Gräfe C, Bruegel M, Zoller M, Maciuga N, Frank S, et al. Myoglobin adsorption and saturation kinetics of the cytokine adsorber Cytosorb® in patients with severe rhabdomyolysis: a prospective trial. Ann Intensive Care. 2024;14(1):96. DOI: https://doi.org/10.1186/s13613-024-01334-x
Downloads
Published
How to Cite
Issue
Section
